Serum vanillylmandelic acid/homovanillic acid contributes to prognosis estimation in patients with localised but not with metastatic neuroblastoma

This publication has 18 references indexed in Scilit:

• N-myc gene amplification and other prognosis-associated factors in neuroblastoma
  Journal of Pediatric Surgery, 1990
• The role of chemotherapy in the treatment of children with neuroblastoma stage IV: The GPO (German Pediatric Oncology Society) experience
  Klinische Padiatrie, 1990
• The value of determination of homovanillic and vanillylmandelic acids in plasma for the diagnosis and follow-up of neuroblastoma in children
  European Journal of Pediatrics, 1987
• Determination of urinary homovanillic and vanillylmandelic acids from dried filter paper samples: Assessment of potential methods for neuroblastoma screening
  Clinical Biochemistry, 1987
• Effect of age on homovanillic and 4-hydroxy-3-methoxymandelic acid levels in plasma
  European Journal of Pediatrics, 1986
• Mass fragmentographic determination of homovanillic and 4-hydroxy-3-methoxy mandelic acids in 50 μl plasma
  Clinica Chimica Acta; International Journal of Clinical Chemistry, 1983
• RAISED NEURON-SPECIFIC ENOLASE IN SERUM OF CHILDREN WITH METASTATIC NEUROBLASTOMA
  The Lancet, 1983
• Biologic Markers in Neuroblastoma
  Published by Springer Nature ,1979
• Initial Urinary Catecholamine Metabolite Concentrations and Prognosis in Neuroblastoma
  Pediatrics, 1978
• ADRENALINE-SECRETING NEUROBLASTOMA IN AN INFANT
  The Lancet, 1957